Delivery Order SPE2DX22D0010-SPE2D826FCX56
- Not listed
- On February 2, 2026, the Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $54,654.55 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of February 3, 2026, was awarded on a non-set-aside basis and represents a task order under AmerisourceBergen's larger contract vehicles supporting...
- On January 16, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $343,533.43 to Amerisourcebergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was competitively awarded with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., operates as a critical vendor for federal...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $247,589.42 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was competitively awarded with no set-aside designation. The contract is structured as a task order under AmerisourceBergen's larger Indefinite Delivery Contract...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,752.23 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was awarded on a non-set-aside basis through open competition. The work will be performed at the awardee's corporate office location in Conshohocken, PA. AmerisourceBergen...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,261.50 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by January 20, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- On January 31, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $224,175.75 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply products. This firm fixed-price delivery order is expected to be completed by February 2, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and...
- On January 12, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,305.77 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,414.86 to AmerisourceBergen Drug Corp (CAGE 0U9U0), headquartered in Conshohocken, Pennsylvania. This firm fixed-price, non-set-aside delivery order has an ultimate completion date of January 20, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including the Department of Defense and Department of...
- On February 3, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $274,044.15 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of February 4, 2026, is issued under the larger Indefinite Delivery Contract (IDC) held by Cencora with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The contract...
- On February 2, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $58,106.93 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of Cencora, Inc. This firm fixed-price delivery order is scheduled for ultimate completion on February 3, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order against AmerisourceBergen's larger...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCX56Delivery Order
On February 3, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,374.48 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of February 4, 2026, was issued as a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which provides comprehensive pharmaceutical products and medical supplies to federal healthcare systems, including the Department of Defense and Department of Veterans Affairs. This delivery order represents a task order executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and medical devices to support military healthcare programs worldwide. The company's federal contracting activity demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical and medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 2/2/26 |